GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » 5-Year Yield-on-Cost %

Orion Infusions (DHA:ORIONINFU) 5-Year Yield-on-Cost % : 0.33 (As of Jul. 19, 2025)


View and export this data going back to . Start your Free Trial

What is Orion Infusions 5-Year Yield-on-Cost %?

Orion Infusions's yield on cost for the quarter that ended in Mar. 2025 was 0.33.


The historical rank and industry rank for Orion Infusions's 5-Year Yield-on-Cost % or its related term are showing as below:

DHA:ORIONINFU' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.09   Med: 1.68   Max: 3.14
Current: 0.33


During the past 13 years, Orion Infusions's highest Yield on Cost was 3.14. The lowest was 0.09. And the median was 1.68.


DHA:ORIONINFU's 5-Year Yield-on-Cost % is ranked worse than
89.3% of 514 companies
in the Drug Manufacturers industry
Industry Median: 2.175 vs DHA:ORIONINFU: 0.33

Competitive Comparison of Orion Infusions's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Infusions's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Orion Infusions's 5-Year Yield-on-Cost % falls into.


;
;

Orion Infusions 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Orion Infusions is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Orion Infusions  (DHA:ORIONINFU) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Orion Infusions 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Orion Infusions's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Infusions Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon I/A, Orion House, Dhaka, BGD, 1208
Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions Headlines

No Headlines